DCGI approves second-third phase human trials of Covid-19 vaccine

Covid-19DCGI approves second-third phase human trials of Covid-19 vaccine


DCGI approves second-third phase human trials of Covid-19 vaccine

New Delhi: The Controller General of Indian Medicine (DCGI) has approved the Serum Institute of India (SII) by Oxford University for the second and third phase human trials of the Develop covid-19 vaccine in the country.

Officials said that Dr. VG Somani, the Drug Controller General had given this approval to SII late on Sunday night. The DCGI first discussed in-depth the recommendations of the Expert Committee (SEC) of covid-19.

According to the senior official, “SII must submit safety-related data to the Central Drugs Standard Control Organization (CDSCO) before the Phase III clinical trial, which has been evaluated by the Data Safety Monitoring Board (DSMB).”

According to the outline of this research, every person involved in the research will be given two doses at an interval of four weeks. This will be followed by an assessment of safety and immunity at fixed intervals.

Officials said that the expert panel of CDSCO has approved the second and third phase of ‘Kovishield’ on healthy adults in India after deliberating deeply on the data from the first and second phase testing.

Share post:



More like this

KTM RC Cup India Begins On Jan 2023, Read here to know more!

Auto Desk - KTM is bringing its RC Cup...

Kajol laughs her heart out in Kapil Sharma’s show

In the new episode of The Kapil Sharma Show, Bollywood actress...

Know Common Sexual Problems in Men in their 30s

Faster metabolism and high libido are the characteristics of men's fertility...

Wanted SP MLA book, found Carrying bogus Aadhar Card

Kanpur (UP): Samajwadi Party (SP) law-maker Irfan Solanki was...